Hawaii Company Develops, Markets High-Tech CleanerAs published in 2008 August, Pacific Business News by Nanea Kalani.
With an eye for what he calls “disruptive technologies,” Honolulu entrepreneur Hank Wuh has entered the commercial market for cleaning nuclear and hazardous waste.
His company, Cellular Bioengineering Inc., has created a cleaning gel that made its way from research and development to the commercial market in approximately two years.
“CBI continues to search the world for significant disruptive ideas which it can nurture and grow into mature products that will change the way the world operates,” said Wuh, who founded his company in Moiliili in 2003.
Read full article here.
DeconGel™ Honored as National Finalist for the Prestigious Christopher Columbus Homeland Security AwardAs published in 2009 October press release by Linda Jameson:
Cellular Bioengineering Inc. (CBI), a Hawaii-based technology accelerator, announced today that it was honored as one of three National Finalists for the Christopher Columbus Foundation Homeland Security Award for 2009. The presentation was made at a National Awards ceremony in the U.S. Capitol in Washington D.C. This award is the result of a year long national competition to identify the individual citizen or company that is making “a measurable and constructive contribution related to basic and/or advanced research in the area of homeland security which will result in a significant and positive benefit to society.”
The Christopher Columbus Fellowship Foundation is an independent Federal government agency established to “encourage and support research, study and labor designed to produce new discoveries in all fields of endeavor for the benefit of mankind.” Governed by a Presidential appointed Board of Trustees, the Foundation seeks to nurture and recognize pioneering individuals and programs which reflect the visionary spirit and pioneering heritage of Christopher Columbus.
CBI was chosen to be a finalist for this prestigious award based on its invention and commercialization of DeconGel™, a product of its CBI Polymers Division. DeconGel™ is a polymeric hydrogel which is the state-of-the-art technology for the effective containment and decontamination of radiological waste and potential nuclear threats as well as chemical and other toxic wastes. Nuclear power plants and government agencies such as the U.S. Department of Energy and the U.S. Department of Defense are early customers and users of DeconGel™. Additional applications of DeconGel™ are being expanded for the decontamination of industrial and military grade hazardous chemicals and biological agents.
Kimberly Owens, the Chair of the Board of Trustees for the Christopher Columbus Foundation, congratulated CBI for its development of DeconGel™. “This hydrogel is a powerful tool in the remediation of radioactive waste and nuclear threats, and future uses are sure to be discovered,” she said. Owens went on to assert that the Board had a very difficult decision to make in choosing between the three National Finalists.
DeconGel™ was funded by the Hawaii Technology Development Venture (HTDV) / Office of Naval Research (ONR). Additional R&D funding was secured through the USAF Force Protection Battlelab, the National Defense Center of Excellence for Research in Ocean Sciences (CEROS) under its contract with the Defense Advanced Research Projects Agency (DARPA), and the Department of Energy.
CBI is a venture accelerator focused on disruptive biomedical and biodefense innovations. Founded in 2003 in Honolulu, Hawaii, CBI works with world-class research institutions to transform novel ideas into commercial products, especially in the area of Chemical, Biological, Radiological, and Nuclear (CBRN) detection and remediation.
“We are extremely honored to be named as a National Finalist for this prestigious award,” said Larry Stack, Chief Operating Officer of CBI Polymers. “Our goal as a company is to accelerate the commercialization of innovative technologies that will have a significant impact upon the security and well being of our nation. This award exemplifies CBI’s motto: Invent. Disrupt. Inspire.”
In 2005, CBI was named a winner of the R&D 100 Award and was nominated for The 2009 National Medal of Technology and Innovation, the highest honor for technological achievement bestowed by the President of the United States on America’s leading innovators.
Read the full story here.
Biotech Firm Sees Cornea Surgery SuccessAs published in 2008 August, Pacific Business News by Nanea Kalani:
Five years after setting out to manufacture the delicate tissue that enables the human eye to see clearly, Cellular Bioengineering Inc. has completed 10 successful cornea implants abroad.
The Honolulu biotechnology firm’s patented material for artificial corneas is being manufactured locally and last December was used for eye surgeries in Europe.
Cellular Bioengineering founder and CEO Hank Wuh said the pilot tests help validate the material’s effectiveness, with all patients — who ranged in age from 16 to 75 — regaining sight. Read more…